Skip to main content
logo
Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
3.600
-0.200 (-5.26%)
At close: Mar 12, 2026, 4:00 PM EDT
3.560
-0.040 (-1.11%)
Pre-market: Mar 13, 2026, 5:38 AM EDT

Altimmune Market Cap

Altimmune has a market cap or net worth of $468.25 million as of March 13, 2026. Its market cap has increased by 10.83% in one year.

Market Cap
468.25M
Enterprise Value
230.48M
1-Year Change
10.83%
Ranking
#3063
Category
Small-Cap
Stock Price
$3.60

Market Cap Chart

Since October 6, 2005, Altimmune's market cap has increased from $81.50M to $468.25M, an increase of 474.54%. That is a compound annual growth rate of 8.93%.

History

DateMarket Cap% Change
Mar 12, 2026468.30M24.42%
Dec 31, 2025376.40M-26.60%
Dec 31, 2024512.80M-15.16%
Dec 29, 2023604.40M-25.26%
Dec 30, 2022808.70M122.17%
Dec 31, 2021364.00M-2.41%
Dec 31, 2020373.00M1,186.21%
Dec 31, 201929.00M61.11%
Dec 31, 201818.00M-42.12%
Dec 29, 201731.10M-85.66%
Dec 30, 2016216.90M77.06%
Dec 31, 2015122.50M6.80%
Dec 31, 2014114.70M17.88%
Dec 31, 201397.30M79.52%
Dec 31, 201254.20M-11.58%
Dec 30, 201161.30M-64.57%
Dec 31, 2010173.00M210.59%
Dec 31, 200955.70M-6.39%
Dec 31, 200859.50M-31.77%
Dec 31, 200787.20M1.04%
Dec 29, 200686.30M4.10%
Dec 30, 200582.90M1.72%
Oct 6, 200581.50M-
View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Prothena Corporation515.72M
Upstream Bio505.80M
Rigel Pharmaceuticals503.39M
Kyverna Therapeutics502.17M
Lexeo Therapeutics499.96M
Century Therapeutics490.44M
Forte Biosciences488.22M
Entrada Therapeutics486.00M
Market Cap Rankings